The American Heart Association (AHA) announced a strategic collaboration with Amazon Web Services: the launch of a cloud-based data marketplace for researchers and clinicians.
The idea to target products for a vertical market is not new. What’s new is our ability to put meaningful data on public clouds that doctors and researchers can use to better understand the patterns of some disease. This is a great leap forward, considering that heart disease is the No. 1 killer in this country.
When released, the AHA Precision Medicine Platform will include a vast array of curated data sets that are centrally stored, searchable, and managed on Amazon’s cloud. This will enable researchers and clinicians to aggregate and analyze the data, including longitudinal cohorts, proteomic, genomic, and gene expression data. For us laymen, this means they will use a precision medicine approach to uncover critical cardiovascular disease insights that translate into medical innovations. In other words, researchers and clinicians will gain the knowledge of thousands of cases, including diagnosis, treatment, and outcome.